Table 2.
TGF-β1 mRNA levels in intestinal tissue of the control group and the study groups
| Sample | Number | TGF-β1 mRNA level (arbitrary units)a | ||||
|---|---|---|---|---|---|---|
| Mean | Median | Min. | Max | SD | ||
| Control | 42 | 0.08596 | 0.04028 | 0.00103 | 0.82469 | 0.16012 |
| IBD-affected area | 90 | 0.15040 | 0.06569 | 0.00068 | 1.59320 | 0.21443 |
| UC | 57 | 0.15512 | 0.07289 | 0.00068 | 0.85378 | 0.18372 |
| CD | 33 | 0.15782 | 0.06569 | 0.00296 | 1.59320 | 0.27999 |
| IBD-unaffected area (active stage of disease) | 41 | 0.03852 | 0.02244 | 0.00108 | 0.30119 | 0.06087 |
aResults from three independent measurements in each sample (including RNA extraction) are presented. Statistical analysis: control vs. IBD (affected area; p = 0.002); control vs. IBD (unaffected area; p = 0.12); control vs. UC (affected area; p = 0.02); control vs. CD (affected area; p = 0.05); UC vs. CD (affected area; p = 1.0)